Stago is a privately-owned family business and, as such, has no short term aims, only long term goals, which to be the best company partner at the heart of haemostasis. Founded on over 60 years of experience, Stago researches, develops, manufactures and distributes its products through a developing network of subsidiaries and remains in control of its strategy at all levels .This makes Stago unique amongst its competitors and is key to its global success.
Stago UK has the advantage of being small enough to give its customers outstanding flexibility, but large enough to provide a complete haemostasis solution to any laboratory, from the largest trust to a routine district general hospital. In the changing face of the NHS, we have established strong links with major primary suppliers and other significant qualified providers necessary to achieve the aims of Government reforms, in particular, the QIPP Initiative based on larger hub laboratories
I am proud and delighted to present to you the Stago UK operation which has changed significantly since founded in 2005 following the acquisition in 2010 of the Trinity Biotech Coagulation business formerly known as Tcoag. This strategic acquisition has placed Stago in an ideal position to develop a strong future in the UK, dealing with the ever-changing face of the National Health Service.
The key to our success in the UK is the dedication and commitment of the entire Stago team, whether that’s from customer service, field service, applications support, product management, the sales team or, of course, our hotline. Every one of our customers has a dedicated support team and, with all support functions cross-trained throughout Stago, you can be sure that one phone call will be all you need to get the right answers. Our aim is to support you, our customer, and manage all your needs and expectations in a friendly and professional manner.
Mervyn Nicholas
General Manager